ChemRoutes Corporation is a private drug discovery technology provider operating at the interface of organic chemistry, chemical biology, drug discovery and nanotechnology. Established in 1999, it is headquartered in Edmonton, Alberta, Canada. ChemRoutes Corporation has a thorough understanding of the drug discovery and development process along with an experienced scientific advisory board. We focus on early stage drug discovery to pre-clinical research. Our proprietary and novel small molecule based scaffolds, building blocks, templates, chemical arrays and new chemical target research spans infectious, neurodegenerative and metabolic diseases, pain, inflammation and oncology. We have consistently delivered results, leading to global partnerships with over 80 pharmaceutical, agrochemical and biotech companies accessing our novel chemistry driven platforms for new molecular targets and biochemical pathways.